Alzheimer Dementia Clinical Trial
Official title:
Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
In this study the investigators explore a pragmatic strategy to increase cognitive screening rates in the community. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood Alzheimer's Disease (AD) biomarkers to identify the best approach for primary care settings.
The investigators aim to perform a cluster-randomized study, exploring the effectiveness, efficiency, and acceptability of a pragmatic strategy to increase cognitive screening rates in the community. Participants will be older adults attending social and cultural centers in the greater Munich area. The investigators will compare the monetary value of different combinations of SCD questionnaires, digital cognitive tests, and blood AD biomarkers to identify the best approach for primary care settings. As secondary aims, qualitative interviews will be conducted with general practitioners (GPs) and their patients to explore the acceptability of the proposed new screening strategy; furthermore, the diagnostic utility of an artificial intelligence-based automated analysis of speech will be assessed. The initiative will not only generate novel insights into the optimal approach for large-scale cognitive screening in the general population, but also contribute to an urgently required cultural change in Germany, resulting in a sustainable solution for effective and efficient early recognition and prevention of dementia. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03255720 -
Application of Diffusion Tensor Imaging in Alzheimer's Disease :Quantification of White Matter Micro-structural Changes
|
N/A | |
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A | |
Withdrawn |
NCT05497817 -
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Completed |
NCT03538522 -
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831
|
Phase 2 | |
Terminated |
NCT03132272 -
Immunoadsorption for Treatment of Alzheimer's Disease
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Enrolling by invitation |
NCT03724136 -
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02267486 -
Exploratory Study for the Validity of QuQu Scale
|
N/A | |
Active, not recruiting |
NCT03748303 -
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
|
Phase 1 | |
Completed |
NCT03611439 -
Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients
|
N/A | |
Completed |
NCT04058886 -
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers
|
N/A | |
Recruiting |
NCT03584568 -
Reappraising Intergeneration Relationships in Dementia Caregiving
|
N/A | |
Not yet recruiting |
NCT05113732 -
Association of Cognition With Functional Mobility in People With Alzheimer's Disease
|
||
Completed |
NCT03811847 -
A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants.
|
Phase 4 | |
Terminated |
NCT03044249 -
A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
|
Phase 2 | |
Active, not recruiting |
NCT03661034 -
Study of Tolerability, Safety and Efficacy of Sensory Stimulation at Multiple Dose Levels to Improve Brain Function (Etude Study)
|
N/A | |
Completed |
NCT03718494 -
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
|
||
Completed |
NCT03602391 -
The Senior Companion Program Plus
|
N/A | |
Completed |
NCT03548584 -
A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
|
Phase 3 |